scholarly journals Are nursing infusion practices delivering full-dose antimicrobial treatment?

2019 ◽  
Vol 74 (12) ◽  
pp. 3418-3422 ◽  
Author(s):  
J Rout ◽  
S Essack ◽  
P Brysiewicz
Keyword(s):  
Infection Prevention ◽  
Nursing Practice ◽  
Antimicrobial Treatment ◽  
Infection Prevention And Control ◽  
Nurse Specialist ◽  
Bedside Nurse ◽  
The Past ◽  
Strong Focus ◽  
And Control

Abstract Antimicrobial stewardship (AMS) has developed over the past decade as a critical tool to promote the appropriate use of antimicrobials in order to contain antimicrobial resistance (AMR) and conserve antimicrobial medicines. Current literature supports the role of the nurse in AMR, with a strong focus on the responsibilities of the nurse in infection prevention and control (IPC), both in the formal role of the IPC nurse specialist, and the more general IPC role of the bedside nurse. There is also growing support for the collaborative role of the nurse in the multidisciplinary AMS team. There is, however, very little literature examining the clinical practice role of the nurse in AMS. In this discussion, we contend that nursing practice may unknowingly contribute to AMR owing to varying methods of administration of intermittent intravenous infusions, resulting in under-dosing of antimicrobial medicines.

Antibiotic resistance in the ICU

2016 ◽  
Author(s):  
Jonathan Edgeworth
Keyword(s):  
Antimicrobial Stewardship ◽  
Infection Prevention ◽  
Antibiotic Use ◽  
Antimicrobial Treatment ◽  
Infection Prevention And Control ◽  
Molecular Testing ◽  
Local Selection ◽  
Appropriate Therapy ◽  
Therapeutic Decision Making ◽  
And Control

The two objectives of ensuring early appropriate antimicrobial treatment for septic patients on the intensive care unit (ICU), and limiting emergence and spread of antimicrobial resistance are both complicated and potentially conflicting. Increasingly unpredictable resistance, particularly amongst Gram-negative bacteria, through both local selection and transmission, and importation of globally successful resistant clones encourages the use of broad-spectrum empiric antimicrobials for septic patients, including in combination. This may lead to a vicious cycle whereby increasing antibiotic use increases resistance, which in turn leads to higher levels of inappropriate therapy. In response, the multi-disciplinary ICU-team implements infection prevention and control, and antimicrobial stewardship programmes. Antimicrobial stewardship programmes provide interventions and guidance to optimize appropriate therapy,whilelimiting unnecessary use through a variety of measures. The development of rapid molecular testing for bacterial identification and antimicrobial susceptibility prediction could potentially bring useful microbiological information to the bedside at the time of therapeutic decision making.

Disinfectants: The role of standardised testing to aid selection. Part 2

2019 ◽  
Vol 20 (3) ◽  
pp. 116-121
Author(s):  
Martyn AC Wilkinson ◽  
Evonne T Curran ◽  
Christina R Bradley
Keyword(s):  
Prevention And Control ◽  
Infection Prevention ◽  
Infection Prevention And Control ◽  
Non Invasive ◽  
Healthcare Environment ◽  
Objective Evidence ◽  
Standardised Testing ◽  
And Control ◽  
Microbial Challenge

Choosing which disinfectant(s) to use in any particular healthcare environment is a far from trivial task and one that is undertaken by Infection Prevention and Control (IPC) professionals on a regular basis. The recent proliferation in the number and type of products designed to disinfect healthcare surfaces makes for a seemingly bewildering range of options. The primary factor to consider is whether the disinfectant is capable of killing the likely (but unknown) microbial challenge. For reusable non-invasive care equipment, standardised testing provides objective evidence for IPC teams. This second paper seeks to explain these tests and the conditions under which they are performed to aid in the IPC teams’ disinfection selection.

The Role of the Laboratory in Infection Prevention and Control Programs in Long-Term–Care Facilities for the Elderly

2001 ◽  
Vol 22 (7) ◽  
pp. 459-463 ◽  
Author(s):  
Andrew E. Simor
Keyword(s):  
Prevention And Control ◽  
Infection Prevention ◽  
Infection Prevention And Control ◽  
Microbiology Laboratory ◽  
Term Care ◽  
Control Programs ◽  
Care Facilities ◽  
And Control

AbstractHospital infection prevention and control programs rely extensively on diagnostic microbiology laboratory testing. However, specimens for microbiological evaluation are less likely to be obtained from elderly residents of long-term–care facilities (LTCFs). In this article, issues regarding laboratory utilization and the potential role of the microbiology laboratory in infection prevention and control programs in LTCFs are reviewed. The role of the laboratory in infection surveillance, in the management of antimicrobial resistance, and in outbreak investigation are highlighted.

Handbook of Pediatric Infection Prevention and Control

2019 ◽  
Author(s):  
Pediatric Infectious Diseases S... PIDS
Keyword(s):  
Infection Prevention ◽  
Real Life ◽  
Infection Prevention And Control ◽  
The Past ◽  
Important Field ◽  
Healthcare Epidemiology ◽  
And Control ◽  
Pediatric Providers ◽  
Infection Preventionists ◽  
Pediatric Infection

In the fields of healthcare epidemiology and infection prevention, evidence to guide pediatric practice has been lacking for quite some time. However, in the past few decades, more and more pediatric clinicians, researchers, epidemiologists, and infection preventionists have been contributing to this important field. This textbook discusses topics that pediatric providers must tackle in many settings: in ambulatory clinics, emergency departments, community hospitals, and freestanding university children’s hospitals. Each chapter opens with a clinical scenario (perhaps you have dealt with a few of these scenarios in real life), and follows with questions that are frequently raised when a solution is sought.

scholarly journals Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update

2014 ◽  
Vol 35 (S1) ◽  
pp. s1-s67 ◽  
Author(s):  
Lisa Saiman ◽  
Jane D. Siegel ◽  
John J. LiPuma ◽  
Rebekah F. Brown ◽  
Elizabeth A. Bryson ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Infection Control ◽  
Prevention And Control ◽  
Infection Prevention ◽  
Lessons Learned ◽  
World Health ◽  
Infection Prevention And Control ◽  
The Past ◽  
Influenza A H1n1 ◽  
And Control

The 2013 Infection Prevention and Control (IP&C) Guideline for Cystic Fibrosis (CF) was commissioned by the CF Foundation as an update of the 2003 Infection Control Guideline for CF. During the past decade, new knowledge and new challenges provided the following rationale to develop updated IP&C strategies for this unique population:1.The need to integrate relevant recommendations from evidence-based guidelines published since 2003 into IP&C practices for CF. These included guidelines from the Centers for Disease Control and Prevention (CDC)/Healthcare Infection Control Practices Advisory Committee (HICPAC), the World Health Organization (WHO), and key professional societies, including the Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA). During the past decade, new evidence has led to a renewed emphasis on source containment of potential pathogens and the role played by the contaminated healthcare environment in the transmission of infectious agents. Furthermore, an increased understanding of the importance of the application of implementation science, monitoring adherence, and feedback principles has been shown to increase the effectiveness of IP&C guideline recommendations.2.Experience with emerging pathogens in the non-CF population has expanded our understanding of droplet transmission of respiratory pathogens and can inform IP&C strategies for CF. These pathogens include severe acute respiratory syndrome coronavirus and the 2009 influenza A H1N1. Lessons learned about preventing transmission of methicillin-resistantStaphylococcus aureus(MRSA) and multidrug-resistant gram-negative pathogens in non-CF patient populations also can inform IP&C strategies for CF.

scholarly journals Role of Physiotherapy Health Care Professionals in Infection Prevention and Control of COVID -19 – A Pandemic Disease

2020 ◽  
Vol 5 (7) ◽  
pp. 1215-1217
Author(s):  
Jarapla Srinivas Nayak ◽  
Tittu Thomas James ◽  
Shubham Menaria ◽  
Dr. Centina Rose John ◽  
Dr. Dhargave Pradnya
Keyword(s):  
Health Care Professionals ◽  
Death Rate ◽  
Prevention And Control ◽  
Infection Prevention ◽  
World Health ◽  
Infection Prevention And Control ◽  
Health Organization ◽  
And Control ◽  
The City

COVID-19 is a new pandemic disease which was reported initially at the city of Wuhan in the Hubei province ofChina on 31 December 2019. 1Recent events have reported its presence in more than 150 countries and with 132758 confirmed cases and a total of 4955 deaths as on 13th March 2020.2Although the death rate due to the disease is 6% or less, the persons who are affected in a short span of time is at an alarming rate.3 In this context, World Health Organization (WHO) have declared the disease as pandemic on 11th March 2020.

Sign in / Sign up

Export Citation Format

Share Document